Checkpoint kinase inhibitors: SAR and radioprotective properties of a series of 2-arylbenzimidazoles
- PMID: 15771432
- DOI: 10.1021/jm0495935
Checkpoint kinase inhibitors: SAR and radioprotective properties of a series of 2-arylbenzimidazoles
Abstract
The discovery of a series of novel, potent, and highly selective inhibitors of the DNA damage control kinase chk2 is disclosed. Here we report the first SAR study around inhibitors of this kinase. High-throughput screening of purified human chk2 led to the identification of a novel series of 2-arylbenzimidazole inhibitors of the kinase. Optimization was facilitated using homology models of chk2 and docking of inhibitors, leading to the highly potent 2-arylbenzimidazole 2h (IC(50) 15 nM). Compound 2h is an ATP-competitive inhibitor of chk2 that dose dependently protects human CD4(+) and CD8(+) T-cells from apoptosis due to ionizing radiation. This work suggests that a selective small molecule inhibitor of chk2 could be a useful adjuvant to radiotherapy, increasing the therapeutic window of such treatment.
Similar articles
-
Novel non-benzimidazole chk2 kinase inhibitors.Bioorg Med Chem Lett. 2006 Apr 1;16(7):1924-8. doi: 10.1016/j.bmcl.2005.12.096. Epub 2006 Jan 25. Bioorg Med Chem Lett. 2006. PMID: 16442290
-
Radioprotection by hymenialdisine-derived checkpoint kinase 2 inhibitors.ACS Chem Biol. 2012 Jan 20;7(1):172-84. doi: 10.1021/cb200320c. Epub 2011 Oct 24. ACS Chem Biol. 2012. PMID: 22004065
-
Identification of novel, selective and potent Chk2 inhibitors.Bioorg Med Chem Lett. 2007 Jan 1;17(1):172-5. doi: 10.1016/j.bmcl.2006.09.067. Epub 2006 Oct 10. Bioorg Med Chem Lett. 2007. PMID: 17035018
-
The Chk2 protein kinase.DNA Repair (Amst). 2004 Aug-Sep;3(8-9):1039-47. doi: 10.1016/j.dnarep.2004.03.033. DNA Repair (Amst). 2004. PMID: 15279791 Review.
-
Design and synthesis of novel tyrosine kinase inhibitors using a pharmacophore model of the ATP-binding site of the EGF-R.J Pharm Belg. 1997 Mar-Apr;52(2):88-96. J Pharm Belg. 1997. PMID: 9193132 Review.
Cited by
-
Characterization of glioma stem cells through multiple stem cell markers and their specific sensitization to double-strand break-inducing agents by pharmacological inhibition of ataxia telangiectasia mutated protein.Brain Pathol. 2012 Sep;22(5):677-88. doi: 10.1111/j.1750-3639.2012.00566.x. Epub 2012 Feb 21. Brain Pathol. 2012. PMID: 22257080 Free PMC article.
-
Structure-based design, discovery and development of checkpoint kinase inhibitors as potential anticancer therapies.Expert Opin Drug Discov. 2013 Jun;8(6):621-40. doi: 10.1517/17460441.2013.788496. Epub 2013 Apr 18. Expert Opin Drug Discov. 2013. PMID: 23594139 Free PMC article. Review.
-
The synthetic lethality of targeting cell cycle checkpoints and PARPs in cancer treatment.J Hematol Oncol. 2022 Oct 17;15(1):147. doi: 10.1186/s13045-022-01360-x. J Hematol Oncol. 2022. PMID: 36253861 Free PMC article. Review.
-
The Expression and Therapeutic Potential of Checkpoint Kinase 2 in Laryngeal Squamous Cell Carcinoma.Drug Des Devel Ther. 2020 Jul 6;14:2613-2622. doi: 10.2147/DDDT.S245267. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 32753843 Free PMC article.
-
Imidazoles as potential anticancer agents.Medchemcomm. 2017 Apr 13;8(9):1742-1773. doi: 10.1039/c7md00067g. eCollection 2017 Sep 1. Medchemcomm. 2017. PMID: 30108886 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Research Materials
Miscellaneous